Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract

NCT00825721 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Nuclear Cataract

Interventions

DRUG: LiquiTears
DRUG: C-KAD Ophthalmic Solution
DRUG: C-KAD Ophthalmic Solution
DRUG: C-KAD Ophthalmic Solution

Sponsor

Chakshu Research, Inc.